Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

AMERICAN CLINICAL SOLUTIONS LLC

NPI: 1588805451 · RUSKIN, FL 33573 · Clinical Medical Laboratory · NPI assigned 03/23/2009

$3.77M
Total Medicaid Paid
318,648
Total Claims
247,299
Beneficiaries
48
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialBROWN, ROGER (PRESIDENT)
NPI Enumeration Date03/23/2009

Related Entities

Other providers sharing the same authorized official: BROWN, ROGER

ProviderCityStateTotal Paid
THE CENTER FOR ADHD, INC MANDEVILLE LA $326K
SUNSTATE PHYSICIANS LLC BOCA RATON FL $77K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 88,820 $1.32M
2019 122,185 $1.48M
2020 35,371 $246K
2021 28,003 $266K
2022 31,515 $336K
2023 11,201 $104K
2024 1,553 $20K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 9,905 8,204 $290K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5,543 4,742 $196K
80325 9,764 7,511 $176K
80345 11,147 8,772 $143K
83992 10,999 8,649 $122K
80356 11,404 8,984 $114K
80346 11,144 8,786 $114K
80367 11,179 8,801 $113K
80372 11,163 8,795 $113K
80373 11,178 8,806 $113K
80361 11,463 9,038 $113K
80365 11,487 9,060 $113K
80368 11,135 8,767 $113K
80348 11,212 8,808 $113K
80357 11,179 8,802 $113K
80366 11,131 8,753 $112K
80354 11,236 8,845 $112K
80358 11,231 8,841 $111K
80360 11,036 8,673 $111K
80353 11,209 8,831 $111K
80359 11,173 8,792 $110K
80370 9,690 7,432 $99K
80364 9,690 7,421 $98K
80349 9,496 7,266 $96K
80355 8,254 6,026 $95K
80334 4,738 3,258 $85K
80323 4,471 3,028 $66K
80338 4,976 3,461 $63K
80371 5,219 3,691 $62K
80339 4,609 3,165 $60K
80337 4,749 3,270 $59K
80344 4,048 2,665 $54K
80321 3,632 2,361 $53K
80352 4,147 2,736 $52K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 336 301 $27K
80362 1,182 1,142 $14K
80369 1,146 1,113 $13K
80324 1,194 1,141 $13K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,452 1,289 $7K
82570 6,022 5,061 $7K
80335 395 377 $5K
80350 388 370 $4K
80332 390 371 $4K
80342 390 374 $4K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 947 562 $3K
80347 16 15 $201.40
80363 137 128 $184.49
80326 16 15 $182.05